The present invention provides: a nucleic acid having an activity of inhibiting the expression of ß2GPI a pharmaceutical composition containing the nucleic acid and a prophylactic or therapeutic medicine for autoimmune diseases such as APS and SLE and thrombosis occurring during hemodialysis, which comprises the nucleic acid.